📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis. (2017)

First Author: Aarnoutse RE

Attributed to: Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/aac.01054-17

PubMed Identifier: 28827417

Publication URI: http://europepmc.org/abstract/MED/28827417

Type: Journal Article/Review

Volume: 61

Parent Publication: Antimicrobial agents and chemotherapy

Issue: 11

ISSN: 0066-4804